Immunogen Inc. (IMGN) Management Discusses Q4 2013 Results (Webcast)

Aug. 2.13 | About: ImmunoGen, Inc. (IMGN)

Immunogen (IMGN): FQ4 EPS of -$0.26 beats by $0.04. Revenue of $3.83M beats by $0.39M. (PR)

The following audio is from an earnings conference call that will begin on August 2, 2013, at 8:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.